goal_code,goal_labelEN,goal_descEN,target_code,target_descEN,indicator_code,indicator_reference,indicator_tier,indicator_custodians,indicator_descEN,series_release,series_tags,series,seriesDescription,geoAreaCode,geoAreaName,level,parentCode,parentName,type,X,Y,ISO3,UN_Member,Country_Profile,years,min_year,max_year,n_years,unitsCode,unitsDesc,reportingTypeCode,reportingTypeDesc,value_2010,value_2011,value_2012,value_2013,value_2014,value_2015,value_2016,value_2017,value_2018,latest_value,basePeriod,valueDetails,footnotes,sources,timeDetails,nature
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",1,World,1,,,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,3.0,4.0,5.0,7.0,7.0,8.0,11.0,11.0,12.0,12.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",100,Bulgaria,4,151,Eastern Europe,Country,25.23763153,42.75731323,BGR,1,1,"[2013, 2014, 2015, 2016, 2017, 2018]",2013,2018,6,PT,Percentage,G,Global,,,,29.2,14.9,4.5,3.2,3.5,5.3,5.3,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",11,Western Africa,4,202,Sub-Saharan Africa,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",124,Canada,4,21,Northern America,Country,-101.6575058,57.72360191,CAN,1,1,"[2015, 2016, 2017, 2018]",2015,2018,4,PT,Percentage,G,Global,,,,,,72.0,73.0,75.0,83.0,83.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",13,Central America,4,419,Latin America and the Caribbean,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,1.0,2.0,5.0,70.0,70.0,66.0,73.0,75.0,78.0,78.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",135,Caucasus and Central Asia,1,,,Group,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,8.0,8.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",14,Eastern Africa,4,202,Sub-Saharan Africa,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,2.0,2.0,2.0,2.0,2.0,6.0,8.0,12.0,12.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",142,Asia,2,1,World,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,2.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",143,Central Asia,3,142,Asia,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,9.0,9.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",144,Sri Lanka,4,34,Southern Asia,Country,80.70489654,7.614693343,LKA,1,1,[2018],2018,2018,1,PT,Percentage,G,Global,,,,,,,,,66.9,66.9,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",145,Western Asia,3,142,Asia,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,2.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",15,Northern Africa,3,2,Africa,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",150,Europe,2,1,World,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,19.0,22.0,26.0,25.0,25.0,26.0,27.0,27.0,27.0,27.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",151,Eastern Europe,3,150,Europe,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,0.0,0.0,1.0,0.0,3.0,3.0,3.0,3.0,3.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",152,Chile,5,5,South America,Country,-71.23029019,-35.2652885,CHL,1,1,"[2015, 2016, 2017, 2018]",2015,2018,4,PT,Percentage,G,Global,,,,,,70.7,73.3,67.4,74.8,74.8,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",154,Northern Europe,3,150,Europe,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,52.0,62.0,74.0,69.0,69.0,67.0,70.0,69.0,75.0,75.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",155,Western Europe,3,150,Europe,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,16.0,18.0,22.0,19.0,20.0,20.0,23.0,23.0,23.0,23.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",17,Middle Africa,4,202,Sub-Saharan Africa,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",170,Colombia,5,5,South America,Country,-73.07446751,3.888209046,COL,1,1,"[2012, 2013, 2014, 2015, 2016, 2017, 2018]",2012,2018,7,PT,Percentage,G,Global,,,50.5,36.5,12.6,23.9,7.6,14.3,29.3,29.3,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",18,Southern Africa,4,202,Sub-Saharan Africa,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,0.0,0.0,0.0,54.0,54.0,56.0,52.0,52.0,52.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",184,Cook Islands,4,61,Polynesia,Country,-159.7711391,-21.22696458,COK,0,1,"[2011, 2013, 2014, 2015, 2016, 2017, 2018]",2011,2018,7,PT,Percentage,G,Global,,76.6,,99.0,99.0,99.0,66.7,99.0,99.0,99.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",19,Americas,2,1,World,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,9.0,12.0,16.0,30.0,31.0,38.0,53.0,58.0,57.0,57.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",196,Cyprus,4,145,Western Asia,Country,33.22285964,35.05659437,CYP,1,1,"[2017, 2018]",2017,2018,2,PT,Percentage,G,Global,,,,,,,,57.2,63.8,63.8,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",199,Least Developed Countries (LDC),1,,,Group,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,1.0,1.0,1.0,1.0,1.0,2.0,4.0,5.0,5.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",2,Africa,2,1,World,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,1.0,1.0,1.0,3.0,3.0,4.0,5.0,7.0,7.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",202,Sub-Saharan Africa,3,2,Africa,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,1.0,1.0,1.0,4.0,4.0,5.0,6.0,8.0,8.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",208,Denmark,4,154,Northern Europe,Country,9.326571283,56.03829721,DNK,1,1,"[2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2011,2018,8,PT,Percentage,G,Global,,69.1,73.6,78.6,68.3,57.1,16.1,36.6,54.3,54.3,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",21,Northern America,3,19,Americas,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,29.0,34.0,32.0,36.0,38.0,46.0,48.0,53.0,49.0,49.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",214,Dominican Republic,5,29,Caribbean,Country,-70.49847576,18.89832088,DOM,1,1,"[2017, 2018]",2017,2018,2,PT,Percentage,G,Global,,,,,,,,31.9,5.7,5.7,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",218,Ecuador,5,5,South America,Country,-78.37005241,-1.447785891,ECU,1,1,"[2014, 2015, 2016, 2017, 2018]",2014,2018,5,PT,Percentage,G,Global,,,,,72.5,8.8,93.8,99.0,90.8,90.8,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",233,Estonia,4,154,Northern Europe,Country,25.84093481,58.68487172,EST,1,1,[2018],2018,2018,1,PT,Percentage,G,Global,,,,,,,,,44.4,44.4,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",242,Fiji,4,54,Melanesia,Country,177.9660884,-17.83301566,FJI,1,1,"[2016, 2017, 2018]",2016,2018,3,PT,Percentage,G,Global,,,,,,,50.2,48.2,46.3,46.3,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",246,Finland,4,154,Northern Europe,Country,23.308447,61.91586738,FIN,1,1,[2018],2018,2018,1,PT,Percentage,G,Global,,,,,,,,,61.9,61.9,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",276,Germany,4,155,Western Europe,Country,10.3806066,51.08862743,DEU,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,26.5,26.5,26.8,29.0,30.5,31.3,31.3,31.3,31.3,31.3,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",29,Caribbean,4,419,Latin America and the Caribbean,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,3.0,3.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",30,Eastern Asia,3,142,Asia,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,2.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",32,Argentina,5,5,South America,Country,-65.14563274,-35.19446255,ARG,1,1,"[2012, 2013, 2014, 2015, 2016, 2017, 2018]",2012,2018,7,PT,Percentage,G,Global,,,37.0,56.2,53.6,47.8,55.2,48.1,57.1,57.1,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",320,Guatemala,5,13,Central America,Country,-91.2312746,15.00273719,GTM,1,1,[2018],2018,2018,1,PT,Percentage,G,Global,,,,,,,,,33.0,33.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",328,Guyana,5,5,South America,Country,-58.97322037,4.788012784,GUY,1,1,[2018],2018,2018,1,PT,Percentage,G,Global,,,,,,,,,9.0,9.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",34,Southern Asia,3,142,Asia,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",340,Honduras,5,13,Central America,Country,-86.59974381,14.82243161,HND,1,1,"[2016, 2017, 2018]",2016,2018,3,PT,Percentage,G,Global,,,,,,,54.7,64.3,60.6,60.6,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",348,Hungary,4,151,Eastern Europe,Country,19.41221519,47.1651448,HUN,1,1,"[2015, 2016, 2017, 2018]",2015,2018,4,PT,Percentage,G,Global,,,,,,72.4,71.9,71.2,70.7,70.7,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",35,South-Eastern Asia,3,142,Asia,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,4.0,4.0,5.0,4.0,4.0,9.0,6.0,4.0,4.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",352,Iceland,4,154,Northern Europe,Country,-19.02116966,64.79134763,ISL,1,1,"[2012, 2013, 2014, 2015, 2016, 2017, 2018]",2012,2018,7,PT,Percentage,G,Global,,,92.3,90.4,89.2,88.0,90.7,88.5,85.0,85.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",36,Australia,4,53,Australia and New Zealand,Country,134.3499412,-25.57717202,AUS,1,1,"[2012, 2013, 2014, 2015, 2016, 2017, 2018]",2012,2018,7,PT,Percentage,G,Global,,,71.9,72.1,74.8,78.7,79.7,80.2,80.2,80.2,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",360,Indonesia,4,35,South-Eastern Asia,Country,113.9174,-0.994582204,IDN,1,1,"[2017, 2018]",2017,2018,2,PT,Percentage,G,Global,,,,,,,,2.9,0.5,0.5,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",372,Ireland,4,154,Northern Europe,Country,-7.121425272,53.25274054,IRL,1,1,"[2012, 2013, 2014, 2015, 2016, 2017, 2018]",2012,2018,7,PT,Percentage,G,Global,,,81.4,84.3,87.0,86.5,73.0,52.1,62.0,62.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",376,Israel,4,145,Western Asia,Country,34.62277992,31.06164552,ISR,1,1,"[2017, 2018]",2017,2018,2,PT,Percentage,G,Global,,,,,,,,50.3,50.3,50.3,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",380,Italy,4,39,Southern Europe,Country,12.57022427,42.79917282,ITA,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,44.4,52.7,55.5,56.2,50.3,56.4,53.8,49.6,40.2,40.2,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",388,Jamaica,5,29,Caribbean,Country,-77.31068409,18.15616857,JAM,1,1,[2018],2018,2018,1,PT,Percentage,G,Global,,,,,,,,,8.1,8.1,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",39,Southern Europe,3,150,Europe,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,35.0,40.0,42.0,43.0,41.0,45.0,45.0,46.0,43.0,43.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",392,Japan,4,30,Eastern Asia,Country,139.2716103,36.6554539,JPN,1,1,"[2013, 2014, 2015, 2016, 2017, 2018]",2013,2018,6,PT,Percentage,G,Global,,,,15.3,1.1,0.5,0.3,0.3,0.3,0.3,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",410,Republic of Korea,4,30,Eastern Asia,Country,127.8610254,36.45201023,KOR,1,1,"[2016, 2017, 2018]",2016,2018,3,PT,Percentage,G,Global,,,,,,,1.9,49.0,62.5,62.5,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",419,Latin America and the Caribbean,3,19,Americas,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,2.0,9.0,28.0,28.0,35.0,55.0,60.0,61.0,61.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",428,Latvia,4,154,Northern Europe,Country,26.42461876,56.64196636,LVA,1,1,"[2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2011,2018,8,PT,Percentage,G,Global,,71.2,62.8,65.4,60.4,55.2,45.3,46.3,53.1,53.1,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",432,Landlocked developing countries (LLDCs),1,,,Group,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,2.0,2.0,3.0,3.0,3.0,6.0,10.0,12.0,12.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",440,Lithuania,4,154,Northern Europe,Country,23.90517807,55.33680309,LTU,1,1,"[2017, 2018]",2017,2018,2,PT,Percentage,G,Global,,,,,,,,20.2,45.9,45.9,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",442,Luxembourg,4,155,Western Europe,Country,6.092656563,49.77679538,LUX,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,16.1,19.3,20.1,20.1,9.6,14.1,14.1,14.1,14.1,14.1,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",458,Malaysia,4,35,South-Eastern Asia,Country,116.8346314,5.452415309,MYS,1,1,"[2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2011,2018,8,PT,Percentage,G,Global,,80.2,83.9,90.1,85.3,85.2,84.0,97.0,83.4,83.4,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",470,Malta,4,39,Southern Europe,Country,14.44617519,35.89194275,MLT,1,1,"[2012, 2013, 2014, 2015, 2016, 2017, 2018]",2012,2018,7,PT,Percentage,G,Global,,,31.0,25.4,99.0,85.7,82.2,78.2,80.9,80.9,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",480,Mauritius,5,14,Eastern Africa,Country,57.568022,-20.28581998,MUS,1,1,"[2017, 2018]",2017,2018,2,PT,Percentage,G,Global,,,,,,,,76.8,80.8,80.8,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",484,Mexico,5,13,Central America,Country,-102.5148166,23.93378032,MEX,1,1,"[2012, 2013, 2014, 2015, 2016, 2017, 2018]",2012,2018,7,PT,Percentage,G,Global,,,4.5,99.0,99.0,93.1,99.0,99.0,98.6,98.6,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",485,"Western Asia (exc. Armenia, Azerbaijan, Cyprus, Israel and Georgia)",1,,,Group,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",5,South America,4,419,Latin America and the Caribbean,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,3.0,11.0,12.0,12.0,24.0,51.0,58.0,58.0,58.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",51,Armenia,4,145,Western Asia,Country,44.93839317,40.29499741,ARM,1,1,[2018],2018,2018,1,PT,Percentage,G,Global,,,,,,,,,2.0,2.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",513,Europe and Northern America,2,1,World,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,23.0,27.0,28.0,29.0,30.0,34.0,35.0,37.0,35.0,35.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",514,Developed Regions,1,,,Group,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,20.0,24.0,27.0,29.0,28.0,32.0,33.0,35.0,34.0,34.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",515,Developing Regions,1,,,Group,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,1.0,2.0,4.0,4.0,5.0,8.0,8.0,9.0,9.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",518,Eastern Asia (excluding Japan),1,,,Group,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",52,Barbados,5,29,Caribbean,Country,-59.5346489,13.13648273,BRB,1,1,"[2014, 2015, 2016, 2017, 2018]",2014,2018,5,PT,Percentage,G,Global,,,,,12.2,29.8,14.9,14.1,24.8,24.8,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",528,Netherlands,4,155,Western Europe,Country,5.331480568,51.86728884,NLD,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,52.3,56.0,58.1,58.9,61.0,61.0,53.4,45.5,45.5,45.5,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",53,Australia and New Zealand,3,9,Oceania,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,8.0,8.0,69.0,70.0,72.0,75.0,76.0,76.0,76.0,76.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",54,Melanesia,3,9,Oceania,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0,3.0,3.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",543,Oceania (exc. Australia and New Zealand),3,9,Oceania,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,0.0,0.0,0.0,0.0,0.0,4.0,4.0,4.0,4.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",554,New Zealand,4,53,Australia and New Zealand,Country,170.4755673,-43.98721568,NZL,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,45.6,44.5,54.8,57.4,58.9,55.7,59.8,56.1,58.0,58.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",56,Belgium,4,155,Western Europe,Country,4.660976456,50.64104975,BEL,1,1,"[2012, 2016, 2017, 2018]",2012,2018,4,PT,Percentage,G,Global,,,61.1,,,,66.8,66.8,66.8,66.8,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",57,Micronesia,3,9,Oceania,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,8.0,0.0,1.0,3.0,3.0,6.0,8.0,31.0,31.0,31.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",578,Norway,4,154,Northern Europe,Country,11.47846389,61.34311134,NOR,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,56.9,72.0,72.8,74.0,78.9,81.3,83.1,84.4,85.6,85.6,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",583,Micronesia (Federated States of),4,57,Micronesia,Country,158.225216,6.880670092,FSM,1,1,"[2017, 2018]",2017,2018,2,PT,Percentage,G,Global,,,,,,,,67.5,60.0,60.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",584,Marshall Islands,4,57,Micronesia,Country,171.0839119,7.110213497,MHL,1,1,"[2010, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,8,PT,Percentage,G,Global,45.6,,3.0,10.5,13.8,22.8,31.2,21.2,28.1,28.1,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",585,Palau,4,57,Micronesia,Country,134.5733878,7.502307591,PLW,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,8.7,4.5,11.1,16.9,19.7,23.7,30.7,35.7,47.5,47.5,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",591,Panama,5,13,Central America,Country,-81.26616623,8.450965746,PAN,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,64.7,78.7,77.8,74.6,80.7,58.0,52.7,68.7,68.5,68.5,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",600,Paraguay,5,5,South America,Country,-60.54854225,-21.70216237,PRY,1,1,"[2013, 2014, 2015, 2016, 2017, 2018]",2013,2018,6,PT,Percentage,G,Global,,,,71.9,68.7,65.6,62.4,55.0,56.3,56.3,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",604,Peru,5,5,South America,Country,-71.82093277,-13.58939705,PER,1,1,"[2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2011,2018,8,PT,Percentage,G,Global,,32.6,19.1,7.9,3.0,53.3,58.3,63.3,68.3,68.3,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",608,Philippines,4,35,South-Eastern Asia,Country,120.8601418,14.16591706,PHL,1,1,"[2016, 2017, 2018]",2016,2018,3,PT,Percentage,G,Global,,,,,,,23.4,0.2,0.7,0.7,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",61,Polynesia,3,9,Oceania,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,4.0,0.0,5.0,4.0,4.0,3.0,4.0,4.0,4.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",62,Central and Southern Asia,2,1,World,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",620,Portugal,4,39,Southern Europe,Country,-7.961599811,39.68509315,PRT,1,1,[2018],2018,2018,1,PT,Percentage,G,Global,,,,,,,,,80.1,80.1,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",64,Bhutan,4,34,Southern Asia,Country,90.45098484,27.39598568,BTN,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2018]",2010,2018,8,PT,Percentage,G,Global,87.4,68.3,72.2,70.8,94.0,94.0,96.7,,89.6,89.6,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",646,Rwanda,5,14,Eastern Africa,Country,29.92310194,-1.999842114,RWA,1,1,"[2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2011,2018,8,PT,Percentage,G,Global,,70.2,71.5,72.9,74.3,75.7,83.8,80.9,84.1,84.1,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",670,Saint Vincent and the Grenadines,5,29,Caribbean,Country,-61.19024321,13.24627968,VCT,1,1,[2018],2018,2018,1,PT,Percentage,G,Global,,,,,,,,,3.6,3.6,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",674,San Marino,4,39,Southern Europe,Country,12.46329038,43.93841766,SMR,1,1,"[2012, 2013, 2014, 2015, 2016, 2017, 2018]",2012,2018,7,PT,Percentage,G,Global,,,21.8,18.0,16.6,17.1,12.7,4.0,16.0,16.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",678,Sao Tome and Principe,5,17,Middle Africa,Country,6.609772265,0.241554875,STP,1,1,[2018],2018,2018,1,PT,Percentage,G,Global,,,,,,,,,95.2,95.2,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",68,Bolivia (Plurinational State of),5,5,South America,Country,-64.66224284,-16.71273412,BOL,1,1,"[2017, 2018]",2017,2018,2,PT,Percentage,G,Global,,,,,,,,62.5,60.9,60.9,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",690,Seychelles,5,14,Eastern Africa,Country,55.46561591,-4.678053059,SYC,1,1,"[2014, 2015, 2016, 2017, 2018]",2014,2018,5,PT,Percentage,G,Global,,,,,89.6,99.0,99.0,89.7,99.0,99.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",702,Singapore,4,35,South-Eastern Asia,Country,103.8107883,1.361009155,SGP,1,1,"[2012, 2013, 2014, 2015, 2016, 2017, 2018]",2012,2018,7,PT,Percentage,G,Global,,,0.1,0.1,0.2,0.1,0.1,0.1,0.1,0.1,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",705,Slovenia,4,39,Southern Europe,Country,14.82209486,46.11958061,SVN,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,44.3,47.3,51.7,39.6,44.1,40.5,40.3,41.8,45.0,45.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",710,South Africa,5,18,Southern Africa,Country,24.67184355,-29.99957544,ZAF,1,1,"[2014, 2015, 2016, 2017, 2018]",2014,2018,5,PT,Percentage,G,Global,,,,,63.3,60.7,61.7,57.4,57.4,57.4,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",72,Botswana,5,18,Southern Africa,Country,23.81380223,-22.18810073,BWA,1,1,"[2015, 2016, 2017, 2018]",2015,2018,4,PT,Percentage,G,Global,,,,,,51.7,82.2,82.2,82.2,82.2,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",722,Small island developing States (SIDS),1,,,Group,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,0.0,0.0,0.0,1.0,1.0,1.0,9.0,5.0,5.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",724,Spain,4,39,Southern Europe,Country,-3.554078296,40.39211472,ESP,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,64.0,67.8,71.9,74.4,72.0,78.2,81.5,87.5,68.5,68.5,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",738,Sub-Saharan Africa (inc. Sudan),1,,,Group,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,1.0,1.0,1.0,4.0,4.0,5.0,6.0,7.0,7.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",740,Suriname,5,5,South America,Country,-55.90626394,4.132603197,SUR,1,1,"[2014, 2015, 2016, 2017, 2018]",2014,2018,5,PT,Percentage,G,Global,,,,,41.2,70.6,38.6,38.1,38.1,38.1,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",746,Northern Africa (exc. Sudan),1,,,Group,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",747,Northern Africa and Western Asia,2,1,World,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",752,Sweden,4,154,Northern Europe,Country,14.3775338,60.60103109,SWE,1,1,"[2016, 2017, 2018]",2016,2018,3,PT,Percentage,G,Global,,,,,,,73.0,72.0,75.0,75.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",753,Eastern and South-Eastern Asia,2,1,World,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,0.0,1.0,2.0,2.0,2.0,2.0,3.0,3.0,3.0,3.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",756,Switzerland,4,155,Western Europe,Country,8.223158,46.96617097,CHE,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,20.0,51.0,51.0,51.0,56.0,56.0,56.0,53.0,57.0,57.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",76,Brazil,5,5,South America,Country,-53.08432878,-10.77668561,BRA,1,1,"[2015, 2016, 2017, 2018]",2015,2018,4,PT,Percentage,G,Global,,,,,,15.5,66.7,76.3,69.2,69.2,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",780,Trinidad and Tobago,5,29,Caribbean,Country,-61.29389504,10.41877263,TTO,1,1,"[2013, 2014, 2015, 2016, 2017, 2018]",2013,2018,6,PT,Percentage,G,Global,,,,8.1,7.3,6.4,6.1,12.5,14.1,14.1,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",784,United Arab Emirates,4,145,Western Asia,Country,53.98279159,23.43322219,ARE,1,1,[2018],2018,2018,1,PT,Percentage,G,Global,,,,,,,,,26.2,26.2,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",795,Turkmenistan,4,143,Central Asia,Country,58.9787665,40.0912346,TKM,1,1,"[2017, 2018]",2017,2018,2,PT,Percentage,G,Global,,,,,,,,95.2,95.2,95.2,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",800,Uganda,5,14,Eastern Africa,Country,32.39100438,1.279557331,UGA,1,1,"[2016, 2017, 2018]",2016,2018,3,PT,Percentage,G,Global,,,,,,,31.2,55.2,71.6,71.6,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",807,North Macedonia,4,39,Southern Europe,Country,21.7007909,41.60048068,MKD,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,33.0,47.8,42.3,34.4,46.6,30.9,44.4,38.0,40.0,40.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",826,United Kingdom of Great Britain and Northern Ireland,4,154,Northern Europe,Country,-2.23830539,53.27691757,GBR,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,78.0,83.8,94.0,85.0,85.3,83.9,82.6,80.0,80.6,80.6,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",834,United Republic of Tanzania,5,14,Eastern Africa,Country,34.80521182,-6.265332606,TZA,1,1,[2018],2018,2018,1,PT,Percentage,G,Global,,,,,,,,,15.7,15.7,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",84,Belize,5,13,Central America,Country,-88.70199554,17.19965901,BLZ,1,1,"[2017, 2018]",2017,2018,2,PT,Percentage,G,Global,,,,,,,,61.2,63.5,63.5,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",840,United States of America,4,21,Northern America,Country,-99.13830311,39.5277871,USA,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,31.9,37.8,35.3,39.4,41.2,44.1,45.4,50.7,46.0,46.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",858,Uruguay,5,5,South America,Country,-56.01387025,-32.8002838,URY,1,1,"[2015, 2016, 2017, 2018]",2015,2018,4,PT,Percentage,G,Global,,,,,,25.9,44.4,43.2,41.9,41.9,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",9,Oceania,2,1,World,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]",2010,2018,9,PT,Percentage,G,Global,5.0,5.0,43.0,43.0,44.0,46.0,48.0,48.0,48.0,48.0,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b01,3.b.1,I,"WHO, UNICEF",Proportion of the target population covered by all vaccines included in their national programme,2020.Q1.G.01,"['health', 'vaccination', 'pharmaceuticals']",SH_ACS_HPV,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",96,Brunei Darussalam,4,35,South-Eastern Asia,Country,114.6288563,4.49736984,BRN,1,1,"[2012, 2013, 2014, 2015, 2016, 2017, 2018]",2012,2018,7,PT,Percentage,G,Global,,,96.6,79.8,79.8,76.6,85.4,87.6,88.6,88.6,,,,WHO and UNICEF HPV coverage estimates,,E: Estimated data
